Keros Therapeutics, Inc.
KROS
Revenue
14.12M
▼-4.04M▼-22.26%
3 Months ChangeAssets
742.78M
▼-14.38M▼-1.90%
3 Months ChangeLiabilities
39.20M
▼-11.23M▼-22.26%
3 Months ChangeFree Cash Flow
160.61M
▲206.11M▲452.93%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-16
Form 8-K
ID: 0001664710-24-000081
2024-09-30
Form 8-K
ID: 0001664710-24-000078
2024-09-03
Form 8-K
ID: 0001664710-24-000075
2024-08-28
Form 8-K
ID: 0001664710-24-000072
2024-08-07
Form 8-K
ID: 0001664710-24-000069
2024-08-07
Form 10-Q
ID: 0001664710-24-000068
2024-08-07
Form 8-K
ID: 0001664710-24-000067
2024-06-17
Form 8-K
ID: 0001664710-24-000059
2024-06-17
Form 8-K
ID: 0001664710-24-000058
2024-06-17
Form 8-K
ID: 0001664710-24-000055